LOS ANGELES--(EON: Enhanced Online News)--Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating Novocure Limited. (“Novocure” or the “Company”) (Nasdaq: NVCR) concerning possible violations of federal securities laws.
“[w]hile barriers to full adoption remain, I am optimistic we will overcome the challenges inherent in bringing a completely new therapy into widespread clinical use.”
If you purchased or otherwise acquired Novocure shares and would like more information regarding the investigation, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at email@example.com.
Novocure creates and markets treatment for solid tumor cancers therapy called the tumor treating fields (“TTFields”). Novocure advertises its proprietary therapy, TTFields delivery system, through the Optune name as a monotherapy treatment for adult patients with glioblastoma brain cancer.
Novocure revealed that its new Optune prescriptions dropped to 657 in the second quarter from 755 in the first. Asaf Danziger, Chief Executive Officer of Novocure, stated, “[w]hile barriers to full adoption remain, I am optimistic we will overcome the challenges inherent in bringing a completely new therapy into widespread clinical use.”
When this information was disclosed to the public, Novocure’s stock fell over 29%, causing investors serious harm.
If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at firstname.lastname@example.org.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.